EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis

Utsav Sen, Charles Coleman, Triparna Sen

Trends in Cancer · 2023-06 · 9 (6) · 480-489

DOI: 10.1016/j.trecan.2023.03.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2023-06. Verfasst von Utsav Sen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Hauptthemen laut MEDLINE: Ferroptosis, Neoplasms. Die Arbeit wurde bisher 245-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer progression is a highly balanced process and is maintained by a sequence of finely tuned metabolic pathways. Stearoyl coenzyme A desaturase-1 (SCD1), the fatty enzyme that converts saturated fatty acids into monounsaturated fatty acids, is a critical modulator of the fatty acid metabolic pathway. SCD1 expression is associated with poor prognosis in several cancer types. SCD1 triggers an iron-dependent cell death called ferroptosis and elevated levels of SCD1 protect cancer cells against ferroptosis. Pharmacological inhibition of SCD1 as monotherapy and in combination with chemotherapeutic agents shows promising antitumor potential in preclinical models. In this review, we summarize the role of SCD in cancer cell progression, survival, and ferroptosis and discuss potential strategies to exploit SCD1 inhibition in future clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisNeoplasmsHumansFatty AcidsFatty Acid DesaturasesCoenzyme AStearoyl-CoA Desaturase

Stichwörter der Autor:innen

NSCLCSCD1cancer therapyfatty acid metabolismferroptosisimmunotherapy

Substanzen

Fatty AcidsFatty Acid DesaturasesCoenzyme AStearoyl-CoA Desaturase

Autor:innen und Institutionen

  • Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • The Bioinformatics for Next Generation Sequencing (BiNGS) Core, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Tisch Cancer Institute, Mount Sinai, New York, NY 10029, USA.
  • Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Tisch Cancer Institute, Mount Sinai, New York, NY 10029, USA. Electronic address: triparnasen@mssm.edu.

Förderung

  • NIH HHS
  • NCI NIH HHS
  • National Institutes of Health
  • National Cancer Institute
  • Congressionally Directed Medical Research Programs
  • Jazz Pharmaceuticals

Zitieren

APA

Sen, U., Coleman, C., & Sen, T. (2023). Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis. Trends in Cancer, 9(6), 480-489. https://doi.org/10.1016/j.trecan.2023.03.003

Vancouver

Sen U, Coleman C, Sen T. Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis. Trends in Cancer. 2023;9(6):480-489. doi:10.1016/j.trecan.2023.03.003

BibTeX
@article{Sen2023,
  author = {Sen, Utsav and Coleman, Charles and Sen, Triparna},
  title = {Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis},
  journal = {Trends in Cancer},
  year = {2023},
  volume = {9},
  number = {6},
  pages = {480--489},
  doi = {10.1016/j.trecan.2023.03.003}
}
Kostenlos starten →